New in Anabolic Drug Checking: Stanozolol analyzable from September

From September 2025, the anabolic-androgenic steroid stanozolol can be analyzed quantitatively as part of anabolic steroid drug checking. This will expand the existing list of substances and make another relevant active ingredient available to users.

The precise analysis supports a well-founded assessment of possible risks and contributes to targeted and effective advice in terms of loss minimization.